Skip to content
PICO Portalanswers from OpenAlex

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

PaperCitations, authors & open-access status

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist is a paper indexed in PICO Portal from OpenAlex.

How many citations does Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist have?

PICO Portalcitation count

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist has 672 citations in the OpenAlex counts PICO Portal stores.

When was Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist published?

PICO Portalyear

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist has 2003 year in the PICO Portal index.

What is the open-access status of Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist?

PICO Portaloa status

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist has closed oa status in the PICO Portal index.

What is the DOI of Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist?

PICO Portaldoi

The DOI for Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist is on the source record.

What is the PMID of Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist?

PICO Portalpmid

The PMID for Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist is on the source record.

What is the OpenAlex record for Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist?

PICO Portalopenalex

The OpenAlex for Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial